TITLE

A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1

AUTHOR(S)
Yan, Yichao; Shen, Zhanlong; Ye, Yingjiang; Jiang, Kewei; Zhang, Hui; Shen, Chao; Mustonen, Harri; Puolakkainen, Pauli; Wang, Shan
PUB. DATE
February 2014
SOURCE
Medical Oncology;Feb2014, Vol. 31 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
93892931

 

Related Articles

  • Recent Advances on Vasohibin Family Regulating Angiogenesis. SHI Ganggang; GAN Jianchen // Tianjin Medical Journal;Sep2014, Vol. 42 Issue 9, p949 

    Angiogenesis is regulated by the local balance between angiogenesis stimulators and inhibitors. Vasohibin family as a novel regulator of angiogenesis involves in the process of various pathophysiology. Vasohibin-1 is the only factor that regulates angiogenesis by means of negative feedback as...

  • Clinical significance of prognostic and predictive markers in colorectal cancer. Longley, DB; McDermott, U; Johnston, PG // Pharmacogenomics Journal;2002, Vol. 2 Issue 4, p209 

    Discusses molecular markers in colorectal cancer (CRC). Introduction to colorectal cancer; Proposed genetic model of CRC; Conclusions.

  • Use of microRNAs in directing therapy and evaluating treatment response in colorectal cancer. da Silveira Andreoli, Silmara Cristiane; Gasparini, Nina Jardim; de Carvalho, Gisele Pereira; Garicochea, Bernardo; Pogue, Robert Edward; de Andrade, Rosângela Vieira // Einstein (16794508);abr-jun2014, Vol. 12 Issue 2, p256 

    Colorectal cancer is the third most common cancer worldwide. Survival and prognosis depend on tumor stage upon diagnosis, and in more than 50% of cases, the tumor has already invaded adjacent tissues or metastasis has occurred. Aiming to improve diagnosis, clinical prognosis and treatment of...

  • The Role of Molecular Markers in Predicting Response to Therapy in Patients with Colorectal Cancer. Shankaran, Veena; Wisinski, Kari B.; Mulcahy, Mary F.; Benson III, Al B. // Molecular Diagnosis & Therapy;Mar2008, Vol. 12 Issue 2, p87 

    Advances in systemic therapy for colorectal cancer have dramatically improved prognosis. While disease stage has traditionally been the main determinant of disease course, several molecular characteristics of tumor specimens have recently been shown to have prognostic significance. Although to...

  • Newer markers do not predict bladder Ca outcomes. Scheck, Anne // Urology Times;Nov2001, Vol. 29 Issue 11, p6 

    Examines the importance of molecular markers for the detections of patients with bladder cancer. Diagnosis of the disease; Survival rate of patients with bladder cancer; Evaluation of molecular markers for the prognosis of the disease.

  • Colorectal cancer molecular biology moves into clinical practice. Colin C Pritchard // Gut;Jan2011, Vol. 60 Issue 1, p116 

    The promise of personalised medicine is now a clinical reality, with colorectal cancer genetics at the forefront of this next major advance in clinical medicine. This is no more evident than in the recent advances in testing of colorectal cancers for specific molecular alterations in order to...

  • Ciblage du récepteur aux facteurs de croissance épithéliaux (REGF) par les inhibiteurs de tyrosine kinase et applications dans les cancers colorectaux. Magné, N.; Toillon, R.-A. // Oncologie;fev2004, Vol. 6 Issue 1, p41 

    EGF receptor is moderately overexpressed in colorectal cancer and it is globally associated to poor prognosis outcome. Thus determination of EGFR level represents a major interest in order to orientate a targeted therapy and to redefine a new prognostic biological marker to treat colorectal...

  • Abstract 10 -- Using Molecular Markers to Guide Colorectal Cancer Therapy. O¿neil, Bert // Oncologist;Oct2012 Supplement, Vol. 17 Issue S2, p5 

    The article presents an abstract discussing the use of molecular markers to guide adjuvant and metastatic therapy of colorectal cancer.

  • Poster Presentations (54-63).  // British Journal of Cancer;1/7/2002 Supplement 1, Vol. 86, p54 

    The article reports on poster presentations displaying information on cancer and its treatment. One of the posters include information on colorectal cancer. Colorectal cancer is one of the most common malignancies in Great Britain. To improve prognosis from colorectal cancer there is an urgent...

  • ANGIOGENESIS-BASED PROGNOSTIC MARKERS IN IMMUNOHISTOCHEMISTRY FOR COLORECTAL CANCER PATIENTS. Ciocâlteu, Adriana; Săftoiu, Adrian; Pirici, Daniel; Cristea, Cosmin; Georgescu, Claudia-Valentina // Internal Medicine / Medicina Interna;2015, Vol. 12 Issue 4, p19 

    Angiogenesis plays a key role in the development and dissemination of colorectal cancer. In advanced stages this malignancy has a poor prognosis due to the inefficacy of the existent treatment and at this point the outcome cannot be completely predicted by common prognostic factors such as lymph...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics